Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05932693 · ClinicalTrials.gov registry record · NA
Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05932693: Completed NA study, sponsored by Yale University.
NCT05932693 is a NA study that has completed, run by Yale University. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05932693, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This pilot sensory experiment will examine cooling from comparable concentrations of WS-3 and menthol to determine appropriate concentrations to use in the main study.
Primary Outcome
Difference in overall flavor intensity, coolness, sweetness and harshness/irritation at each e-cigarette condition as measured by the computerized Generalized Labeled Magnitude Scale (gLMS). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. The Generalized Labeled Magnitude Scales (gLMS) are category ratio scales with seven semantic labels: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "stro
Interventions
- OTHER E-liquid coolant (WS-3, 0.05%)
- OTHER E-liquid coolant (WS-3, 0.1%)
- OTHER E-liquid coolant (WS-3, 0.5%)
- OTHER E-liquid coolant (WS-3, 1.0%)
- OTHER E-liquid coolant (WS-3, 2.0%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-09-03 |
| Est. Completion | 2025-01-09 |
| Phase | NA |
What the finished NCT05932693 record still lists
NCT05932693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which E-liquid coolant (WS-3, 0.05%) is the first listed.
NCT05932693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05932693 about?
NCT05932693 is a clinical study titled "Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0". This pilot sensory experiment will examine cooling from comparable concentrations of WS-3 and menthol to determine appropriate concentrations to use in the main study.
What is the current status of trial NCT05932693?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-09-03. Estimated completion is 2025-01-09.
What interventions are being tested in trial NCT05932693?
The interventions under investigation include: E-liquid coolant (WS-3, 0.05%) (OTHER), E-liquid coolant (WS-3, 0.1%) (OTHER), E-liquid coolant (WS-3, 0.5%) (OTHER), E-liquid coolant (WS-3, 1.0%) (OTHER), E-liquid coolant (WS-3, 2.0%) (OTHER).
Who is sponsoring clinical trial NCT05932693?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05932693's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI